U.S. flag
      An official website of the United States government, Department of Justice.
        Here's how you know
      Here's how you know**Official websites use .gov**
            
            A **.gov** website belongs to an official government organization in the United States.
      **Secure .gov websites use HTTPS**
            
            A **lock** (
            A locked padlock
            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Menu

      
        close

            
            
                                              About NIJ
        
                    
  
          About NIJ
      
    
          The NIJ Director
          How NIJ Is Organized
          Mission and Guiding Principles
          Research and Development Process
          Strategic Framework
          Assessments of NIJ
          Annual Reports & Reports to Congress
          Staff Directory
          Funding & Awards
        
                    
  
          Funding & Awards
      
    
          Current Funding
          Forthcoming Funding
          Expired Funding
          Awards: Listing of Funded Projects
          Guidance for Applicants and Awardees
          Fellowship & Student Programs
          Travel Scholarships
          NIJ Challenge Program
          Library & Multimedia
        
                    
  
          Library & Multimedia
      
    
          NIJ Journal
          Podcasts
          Publications Listing
          Multimedia Listing
          Rated Practices on CrimeSolutions
          Rated Programs on CrimeSolutions
          Software & Databases
          Datasets
          Patents
          Topics
        
                    
  
          Topics
      
    
          Article Listing
          Corrections
          Courts
          Crime Prevention
          Crimes
          Drugs and Crime
          Equipment and Technology
          Forensic Sciences
          Youth Justice
          Justice System Reform
          Law Enforcement
          Tribal Crime and Justice
          Victims of Crime
          Events
        
                    
  
          Events
      
    
          NIJ 2024 Research Conference
          Scheduled Events
          On-Demand Events
          Research Meetings & Workshops
          NIJ-Hosted Online Training

                            
                                About
          Contact Us
          Subscribe
          Topics A-Z
                  Share
FacebookXLinkedInRedditPinterestEmail Home
                            Events
 Cannabinoid Pharmacology: Three Decades of Controlled Human Cannabinoid Administration Studies Event Dates
              August 1, 2023, 1:00 pm
 – 2:00 pmEastern
Event Duration
              1 Hour
Location
              Online

Register

Important research findings of three decades of controlled human cannabinoid administration studies conducted at the National Institute on Drug Abuse (NIDA), National Institutes of Health are described. Study design is critical to collecting data. Parameters to consider include dose and route of administration, controls, blinding, cross-over design, sensitivity of the pharmacodynamic measures, and selection of biological matrices and target analytes. Pharmacodynamic measures include subjective drug effects, cardiovascular effects, cognitive performance, simulated driving performance, and standardized field sobriety tests. While pharmacokinetic considerations include which biological matrices to collect, times and frequency of collection, and target analytes to quantify.

Investigations initially focused on acute cannabis or ∆9-tetrahydrocannabinol (THC) administration by the smoked route, but later also investigated the pharmacodynamics and pharmacokinetics of vaporized and oral cannabis in men and women, demonstrating the importance of self-titration of the delivered dose to achieve the desired psychological and physiological effects and the lack of linear concentration-effect curves due to counter-clockwise hysteresis. The study employed a continuous blood withdrawal pump collecting 5 mL of blood a minute during cannabis smoking to describe what occurs during inhalation, rather than after the end of inhalation that was routinely investigated. Later, the absorption, distribution, metabolism, and excretion of THC, cannabidiol (CBD), cannabinol (CBN), cannabigerol (CBG), ∆9-tetrahydrocannabivarin (THCV), and their metabolites ∆9-tetrahydrocannabinol (THC)-glucuronide, 11-hydroxy-THC (11-OH-THC), 11-nor-9-carboxy-THC (THCCOOH), THCCOOH-glucuronide and 11-nor-9-carboxy-THCV (THCVCOOH) was studied following the same smoked, vaporized and oral cannabis doses in the same individuals. Other novel data were generated when the important population of chronic frequent cannabis users was investigated. The study documented extended THC presence at low concentrations in blood for as long as a month, residual psychomotor impairment for at least three weeks, and downregulation of CB1 cannabinoid receptors in the brain that normalized with sustained cannabis abstinence of one month. Rimonabant, the first specific CB1-cannabinoid receptor antagonist, was also administered to document that THC produces its effects through the CB1-cannabinoid receptor.

Controlled drug administration studies are valuable tools for acquiring a detailed understanding of the pharmacodynamic and pharmacokinetic profiles of cannabinoids. THC is the primary psychoactive cannabinoid in cannabis with the potential to negatively impact cognitive and psychomotor performance and workplace safety. These studies establish behavioral and subjective effect profiles while simultaneously collecting pharmacokinetics data. This information is important for understanding the onset, peak, and duration of effects and their corresponding concentrations in biological fluids. Results from these studies can guide regulations related to workplace drug testing, driving under the influence, post-incident workplace testing, and public health initiatives.

Many US states decriminalized medical and/or recreational cannabis use, focusing attention from establishing cannabis use to demonstrating impairment from the drug regardless of whether the test is for the purpose of driving while impaired, workplace post-incident or fitness for duty. Clinical studies are increasingly important to help inform regulators about the benefits and limitations of current laboratory tests and establishing new tests to accomplish these aims.

**Detailed Learning Objectives**

Attendees will be able to describe THC and metabolite time-concentration profiles and the concentration-effect curves of inhaled cannabis, including its prominent counter-clockwise hysteresis.
	Attendees will be able to describe the pharmacokinetics of smoked, inhaled and oral cannabis.
	Attendees will be able to describe how THC effects on the brain result in cognitive and psychomotor impairment.
Learn more and register
  
  
          Details
Event Type
              Webinar
    Event Option(s)
          On demand

Sponsor(s) / Host(s)

National Institute of Justice (NIJ), U.S. Department of Justice;Forensic Technology Center of Excellence
    Contact
          Forensic Technology Center of Excellence

  Link
              Contact the FTCoE with questions about this event

  Email
              [email protected]

  Registration Dates
              July 14, 2023 - August 1, 2023

  Registration Status
              Open

  Cost
              $0

  Eligibility
              Open to all

  Credits
              Certificate of completion
    
  
Read more about
    
            Driving Under the Influence (DUI)
        Field sobriety tests
        National Institute on Drug Abuse
        Social and Behavioral Science
        Evaluation
  
Date Created: July 14, 2023
    
          Side navigation
  

        

  
  
              NIJ 2024 Research Conference
    
      
            
            
            
      Scheduled Events
    
      
            
            
            
      On-Demand Events
    
      
            
            
            
      Research Meetings & Workshops
    
      
            
            
            
      NIJ-Hosted Online TrainingSimilar Events
        
                      DEIA: What I learned from the AAFS Diversity Outreach Committee
 Top

      National Institute of Justice

        
        
                        About NIJ
                    About NIJ
      
    
                  How NIJ Is Organized
      
    
                  NIJ Director
      
    
                  Research Disclaimer
      
    
                  Funding & Awards
                    Funding & Awards Home
      
    
                  Awards Listing
      
    
                  Current Funding
      
    
                  Guidance for Applicants and Awardees
      
    
                  Resources
                    Events
      
    
                  Podcasts
      
    
                  Publications
      
    
                  Topics
      
    
                  Multimedia
      
    
                  Reuse Policy
      
    
                  Contacts
                    Contact NIJ
      
    
                  Staff Directory
      
    
                  Submit a FOIA Request
      
    
                  File a Civil Rights ComplaintFacebook
          
                      X
          
                      YouTube
  

      810 7th St. NW, Washington, D.C. 20531
      
              Secondary Footer link menu
            Accessibility
              Plain Language
              Privacy Policy
              Legal Policies and Disclaimer
              No FEAR Act
              Freedom of Information Act
              USA.gov
              Justice.gov